Intuitive Surgical, Inc. vs Procter & Gamble Co — how do they compare? Intuitive Surgical, Inc. trades at $426.62 (market cap $146.76B), while Procter & Gamble Co trades at $151.24 (market cap $349.77B). The key difference: Procter & Gamble Co is far larger — about 2.4× Intuitive Surgical, Inc.'s market cap, and Procter & Gamble Co pays a 2.89% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Procter & Gamble Co for 131 Days on average.
| ISRG | PG | |
|---|---|---|
Market Cap | $146.76B | $349.77B |
Volume | 2,529,814 | 10,055,825 |
Sector | Health | Consumer Staples |
52-Week High | $592.85 | $167.18 |
52-Week Low | $332.02 | $138.10 |
Typical Hold Time | 84 Days | 131 Days |
Enterprise Value | $141.54B | $375.61B |
Dividend Yield | — | 2.89% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.
ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.
Procter & Gamble (PG) trades at $150.87, up 2.06% today, showing strong momentum near its consensus price target of $160.13. The stock maintains a bullish technical outlook with moving averages supporting upward momentum, while fundamentals reveal consistent earnings beats and robust profitability with 18.44% net margins. Recent corporate developments include a new WNBA partnership and a $1.09 dividend declaration, reinforcing its stable income appeal.
PG offers reliable growth with three consecutive earnings beats and strong cash flow generation, though premium valuation multiples pose near-term risk. The company's supply chain enhancements and dividend track record provide stability, but investors face headwinds from soft demand concerns and elevated P/E ratios. Wall Street maintains a bullish stance with 53% buy ratings, suggesting moderate upside potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →